Universal Beteiligungs und Servicegesellschaft mbH Acquires 86,206 Shares of Sabra Healthcare REIT, Inc. $SBRA

Key Points

• Universal Beteiligungs und Servicegesellschaft mbH raised its stake in Sabra Healthcare REIT by 10.4%, buying 86,206 shares to hold 918,167 shares (about 0.37% of the company) valued at roughly $17.42 million.
• Sabra missed quarterly EPS ($0.11 vs. $0.37 expected) despite revenue rising 16.2% year‑over‑year, and the company set FY2026 guidance of 1.550–1.590 EPS against analysts' expectations of ~1.51 EPS.
• Dividend yield and payout: Sabra pays a $0.30 quarterly dividend (annualized $1.20) for a ~6.0% yield, but its payout ratio is unusually high at 187.5%.

Universal Beteiligungs und Servicegesellschaft mbH raised its holdings in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 10.4% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 918,167 shares of the real estate investment trust's stock after buying an additional 86,206 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH owned about 0.37% of Sabra Healthcare REIT worth $17,420,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Founders Capital Management bought a new stake in Sabra Healthcare REIT in the third quarter valued at approximately $28,000. Danske Bank A S bought a new stake in Sabra Healthcare REIT in the third quarter valued at approximately $30,000. Larson Financial Group LLC raised its stake in Sabra Healthcare REIT by 42.3% in the third quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust's stock valued at $35,000 after buying an additional 553 shares during the period. First Horizon Corp bought a new stake in Sabra Healthcare REIT in the fourth quarter valued at approximately $44,000. Finally, Covestor Ltd raised its stake in Sabra Healthcare REIT by 23,720.0% in the third quarter. Covestor Ltd now owns 2,382 shares of the real estate investment trust's stock valued at $45,000 after buying an additional 2,372 shares during the period. Institutional investors own 99.40% of the company's stock.

Sabra Healthcare REIT Price Performance

Sabra Healthcare REIT stock opened at $20.09 on Friday. Sabra Healthcare REIT, Inc. has a 12 month low of $17.04 and a 12 month high of $21.07. The stock's 50 day moving average is $20.21 and its 200-day moving average is $19.26. The company has a current ratio of 4.29, a quick ratio of 4.29 and a debt-to-equity ratio of 0.90. The company has a market capitalization of $5.07 billion, a price-to-earnings ratio of 31.39, a PEG ratio of 1.59 and a beta of 0.67.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last posted its earnings results on Thursday, February 12th. The real estate investment trust reported $0.11 EPS for the quarter, missing the consensus estimate of $0.37 by ($0.26). Sabra Healthcare REIT had a net margin of 20.09% and a return on equity of 5.63%. The firm had revenue of $201.35 million during the quarter, compared to analyst estimates of $201.97 million. During the same period in the previous year, the company posted $0.36 EPS. Sabra Healthcare REIT's revenue for the quarter was up 16.2% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Equities research analysts expect that Sabra Healthcare REIT, Inc. will post 1.51 EPS for the current year.

Sabra Healthcare REIT Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, February 27th. Stockholders of record on Friday, February 13th were given a $0.30 dividend. The ex-dividend date of this dividend was Friday, February 13th. This represents a $1.20 annualized dividend and a dividend yield of 6.0%. Sabra Healthcare REIT's dividend payout ratio is presently 187.50%.

Analysts Set New Price Targets

Several research firms have issued reports on SBRA. Wall Street Zen lowered Sabra Healthcare REIT from a "hold" rating to a "sell" rating in a research note on Friday, January 23rd. Scotiabank upped their price objective on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a "sector perform" rating in a research note on Monday, March 2nd. Weiss Ratings upgraded Sabra Healthcare REIT from a "buy (b+)" rating to a "buy (a-)" rating in a research note on Wednesday, March 18th. UBS Group upped their price objective on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a "neutral" rating in a research note on Thursday, February 19th. Finally, Cantor Fitzgerald upped their price objective on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a "neutral" rating in a research note on Tuesday, February 17th. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $22.00.

Sabra Healthcare REIT Profile

Sabra Healthcare REIT, Inc NASDAQ: SBRA is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra's tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.

Want to see what other hedge funds are holding SBRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.